July 11, 2019: Seroconversion while on long-acting contraceptives; cardiovascular risk in people with HIV; suboptimal testing in high-prevalence U.S. areas; E/C/F/TAF may be suitable for PEP.
New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.
A dial-in hotline program in New York City has helped qualified patients access post-exposure prophylaxis (PEP) at their local pharmacies, raising the possibility that remote screening methods could be an important way to bolster PEP use.
"I truly believe that HIV care remains an extraordinarily gratifying aspect of ID clinical practice," Paul Sax, M.D., writes. "Which is why it’s critical that ID doctors continue to do it."
Researchers examining issues facing post-exposure prophylaxis (PEP) users found that 74% of study participants had at least one psychosocial issue, including depression and/or problematic drug or alcohol use.
After the departure from clinical practice of three colleagues, Paul Sax, M.D., reflects on the state of U.S. health care and its frustrating "medicine-as-a-business" model.
Doctors in Toronto did something novel: They prescribed post-exposure prophylaxis (PEP) in advance so that in case of potential exposure patients can initiate PEP on their own and then subsequently seek medical attention.
A Necessary Moment of Self-Care for Black Gay, Trans and Queer People Living and Working on the HIV Front Lines
"Although we may be the only thing that our clients have, we are neither saviors nor superheroes," writes George M. Johnson, who has been doing community work since he was 14.
Researchers in Ottawa conducted a two-year study based in sexual health clinics in the community where nurse-led programs assessed the demand for and use of PEP.
A review of several thousand PEP users at Montreal's Clinique Médicale l'Actuel found "a regimen that included the fixed-dose combination of tenofovir + FTC (Truvada) was well tolerated and that patients reported that they generally adhered well to P...